Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 169   

Articles published

GSK 1,501.50 +3.00 (0.20%)
price chart
Research Analysts' Weekly Ratings Updates for GlaxoSmithKline plc (GSK)
1/5/2015 - GlaxoSmithKline plc was downgraded by analysts at JPMorgan Chase & Co. from a �neutral� rating to an �underweight� rating.
Why I'm Selling GlaxoSmithKline plc And Buying Shire PLC
Finding a company that has the perfect blend of both growth and income is a difficult game to play. However, it looks as if Shire (LSE: SHP) could be the perfect pick.
Pfizer Inc. Has AstraZeneca plc Or GlaxoSmithKline plc In Its Sights
However, it has since emerged that Pfizer's CEO likes the look of GlaxoSmithKline (LSE: GSK), which currently has a market value of �72.4bn (about $112.2bn), which is more than the �69bn offer Pfizer made for Astra last year.
GlaxoSmithKline plc Price Target Raised to GBX 1620 (GSK)
GlaxoSmithKline plc (LON:GSK) had its target price lifted by Berenberg Bank from GBX 1,540 ($23.11) to GBX 1,620 ($24.31) in a research note released on Friday morning.
GlaxoSmithKline plc Given "Underweight" Rating at JPMorgan Chase ...  Dakota Financial News
GlaxoSmithKline plc Stock Rating Reaffirmed by JPMorgan Chase & Co. (GSK)  WKRB News
J Sainsbury plc Is Digging Its Own Grave, But GlaxoSmithKline plc Is Looking ...
If you're like me, and you're cautious with your money, you'll have had a good hard look at some of the FTSE 100's best 'defensive' stock offerings over the past 12 months.
How GlaxoSmithKline PLC And AstraZeneca PLC Will Fare In 2015
If you were to ask investors at the beginning of the year whether you should invest in GlaxoSmithKline (LSE: GSK) or AstraZeneca (LSE: AZN), I think most would have picked the former rather than the latter.
Related articles »  
Why I Think Shire plc Will Outperform AstraZeneca plc And GlaxoSmithKline plc ...
You probably know everything about GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) by now: a bribery scandal in China, falling earnings and a patent cliff have all weighed on its equity valuation in recent times.
Profit From 2015's Dividend Bonanza With GlaxoSmithKline plc, Royal Dutch ...
At present Glaxo offers a regular dividend of around 80p per share, a yield of 5.7%, an impressive figure that you'd be hard pressed to find elsewhere.
How Will GlaxoSmithKline plc, AstraZeneca plc And Shire PLC Fare During 2015?
The big story of the last few years in pharmaceuticals was the way big operators such as GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) and AstraZeneca (LSE: AZN) (NYSE: AZN.US) lost business and profit margins thanks to generic competitors swooping in ...
Will Crowd Sourcing Help AstraZeneca plc And GlaxoSmithKline plc Rekindle ...  Yahoo Finance UK
Related articles »  
Company News: GlaxoSmithKline plc (ADR) (NYSE:GSK)
GlaxoSmithKline plc (ADR) (NYSE:GSK) announced the simultaneous availability of two of its recently approved products for the treatment of asthma and COPD to retail pharmacies in the US.
GlaxoSmithKline plc Downgraded by New Street Research (GSK)  Ticker Report
GlaxoSmithKline plc (ADR) Witness Large Outflow of Money  Stafford Daily